Cite Filings / DLB / 0000950170-25-012351
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13D/A

Beneficial Ownership Report

Dolby Laboratories, Inc. · Filed 2025-02-03 · Acc 0000950170-25-012351

Documents 1

  • SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

  • 2026-02-13 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-02-06 4 Director acquired 3,140 shares (grant or award)
  • 2025-02-06 4 Director acquired 3,140 shares (grant or award)
  • 2025-02-05 144 Sale of Securities
  • 2025-02-03 4 EVP, Gen. Counsel & Secretary sold 40,000 shares at an average $84.88 ($3,395,103)
  • 2025-02-03 4 Director sold 1,000 shares at $84.90 ($84,900)
  • 2025-02-03 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…